These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21132271)

  • 1. Pyruvate promotes tumor angiogenesis through HIF-1-dependent PAI-1 expression.
    Jung SY; Song HS; Park SY; Chung SH; Kim YJ
    Int J Oncol; 2011 Feb; 38(2):571-6. PubMed ID: 21132271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma.
    Geis T; Döring C; Popp R; Grossmann N; Fleming I; Hansmann ML; Dehne N; Brüne B
    Exp Cell Res; 2015 Feb; 331(1):46-57. PubMed ID: 25489981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXO4 induces human plasminogen activator inhibitor-1 gene expression via an indirect mechanism by modulating HIF-1alpha and CREB levels.
    Dimova EY; Samoylenko A; Kietzmann T
    Antioxid Redox Signal; 2010 Aug; 13(4):413-24. PubMed ID: 20136501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of PAI-1 expression by tumor necrosis factor alpha in endothelial cells is mediated by its responsive element located in the 4G/5G site.
    Swiatkowska M; Szemraj J; Cierniewski CS
    FEBS J; 2005 Nov; 272(22):5821-31. PubMed ID: 16279946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MAPK pathway and HIF-1 are involved in the induction of the human PAI-1 gene expression by insulin in the human hepatoma cell line HepG2.
    Dimova EY; Kietzmann T
    Ann N Y Acad Sci; 2006 Dec; 1090():355-67. PubMed ID: 17384280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of plasminogen activator inhibitor-1 expression by insulin-like growth factor-1 via MAP kinases and hypoxia-inducible factor-1 in HepG2 cells.
    Dimova EY; Möller U; Herzig S; Fink T; Zachar V; Ebbesen P; Kietzmann T
    Thromb Haemost; 2005 Jun; 93(6):1176-84. PubMed ID: 15968405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adaptor protein Ruk/CIN85 activates plasminogen activator inhibitor-1 (PAI-1) expression via hypoxia-inducible factor-1alpha.
    Samoylenko A; Dimova EY; Kozlova N; Drobot L; Kietzmann T
    Thromb Haemost; 2010 May; 103(5):901-9. PubMed ID: 20216986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha.
    Liao H; Hyman MC; Lawrence DA; Pinsky DJ
    FASEB J; 2007 Mar; 21(3):935-49. PubMed ID: 17197388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation.
    Li MH; Miao ZH; Tan WF; Yue JM; Zhang C; Lin LP; Zhang XW; Ding J
    Clin Cancer Res; 2004 Dec; 10(24):8266-74. PubMed ID: 15623602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription.
    Diebold I; Djordjevic T; Hess J; Görlach A
    Thromb Haemost; 2008 Dec; 100(6):1021-8. PubMed ID: 19132225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice.
    Huang B; Deora AB; He KL; Chen K; Sui G; Jacovina AT; Almeida D; Hong P; Burgman P; Hajjar KA
    Blood; 2011 Sep; 118(10):2918-29. PubMed ID: 21788340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor-1 and hypoxia response elements mediate the induction of plasminogen activator inhibitor-1 gene expression by insulin in primary rat hepatocytes.
    Kietzmann T; Samoylenko A; Roth U; Jungermann K
    Blood; 2003 Feb; 101(3):907-14. PubMed ID: 12393531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The upstream stimulatory factor-2a inhibits plasminogen activator inhibitor-1 gene expression by binding to a promoter element adjacent to the hypoxia-inducible factor-1 binding site.
    Samoylenko A; Roth U; Jungermann K; Kietzmann T
    Blood; 2001 May; 97(9):2657-66. PubMed ID: 11313255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor-1-mediated regulation of semaphorin 4D affects tumor growth and vascularity.
    Sun Q; Zhou H; Binmadi NO; Basile JR
    J Biol Chem; 2009 Nov; 284(46):32066-74. PubMed ID: 19762474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Cyr61/CCN1 expression by hypoxia through cooperation of c-Jun/AP-1 and HIF-1α in retinal vascular endothelial cells.
    You JJ; Yang CM; Chen MS; Yang CH
    Exp Eye Res; 2010 Dec; 91(6):825-36. PubMed ID: 21029732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1.
    Fink T; Kazlauskas A; Poellinger L; Ebbesen P; Zachar V
    Blood; 2002 Mar; 99(6):2077-83. PubMed ID: 11877282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F; Das B
    Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of SENP1 in endothelial cells contributes to hypoxia-driven VEGF expression and angiogenesis.
    Xu Y; Zuo Y; Zhang H; Kang X; Yue F; Yi Z; Liu M; Yeh ET; Chen G; Cheng J
    J Biol Chem; 2010 Nov; 285(47):36682-8. PubMed ID: 20841360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of hypoxia and TNF-alpha on production of PAI-1 in human proximal renal tubular cells.
    Li X; Kimura H; Hirota K; Kasuno K; Torii K; Okada T; Kurooka H; Yokota Y; Yoshida H
    Kidney Int; 2005 Aug; 68(2):569-83. PubMed ID: 16014034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.